HEMO — Hemogenyx Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Institutional investment
Brief: Hemogenyx Pharma Announces Administration Of First-In-Human Treatment With HG-CT-1
Issue of convertible loan notes
Placing to raise £340,000
Brief: Hemogenyx Pharmaceuticals Opens First Clinical Site For HG-CT-1 Trial
Ultrafast CAR-T Manufacturing
Admission of New Ordinary Shares and New ISIN
CBR Macrophage Delivery Update
Notice of Extraordinary General Meeting
IRB Approval for Phase I Clinical Trial
Institutional Investment
Strategic Investment from Prevail Partners, LLC
Half-year Report
CDX Development Update
Macrophage-Directed Therapies Summit Presentation
Operations Update
Posting of Annual Report & Notice of AGM
Final Results
Placing to Raise US$4.2 million